Hearing on “Lowering Prescription Drug Prices: Deconstructing the Drug Supply Chain”
The Subcommittee on Health of the Committee on Energy and Commerce held a hearing on Thursday, May 9, 2019, at 10 a.m. in room 2322 of the Rayburn House Office Building. The hearing is entitled “Lowering Prescription Drug Prices: Deconstructing the Drug Supply Chain.”
Key Documents
Memorandum from Chairman Pallone to the Subcommittee on Health
Opening Statement of Chairman Pallone as prepared for delivery
Opening Statement of Subcommittee Chairwoman Eshoo as prepared for delivery
Livestream
Witnesses
Panel I
Justin McCarthy
Senior Vice President, Patient & Health Impact Group
Pfizer
Kave Niksefat
Vice President, Value and Access
Amgen
Jeffrey Hessekiel
Executive Vice President & General Counsel
Exelixis
Amy Bricker
Senior Vice President, Supply Chain
Express Scripts
Brent Eberle
Chief Pharmacy Officer
Navitus Health Solutions
Panel II
Estay Greene
Vice President of Pharmacy Services
Blue Cross Blue Shield of North Carolina
Lynn Eschenbacher
Chief Pharmacy Officer
Ascension
Jack Resneck, M.D.
Chair, Board of Trustees
American Medical Association
Richard Ashworth
President of Pharmacy
Walgreens
Leigh Purvis
Director of Health Services Research
AARP